Carl Kraus
Hoofd Techniek/Wetenschap/O&O bij AQUESTIVE THERAPEUTICS, INC.
Vermogen: 1 M $ op 30-04-2024
Profiel
Carl N.
Kraus was the founder of Arrevus, Inc. founded in 2015, where he held the titles of Chairman, President & Chief Executive Officer from 2017 to 2021.
Currently, he is the Medical Director at i3 Research, Inc. and the Chief Medical Officer at Aquestive Therapeutics, Inc. since 2023.
Previously, he served as the Chief Medical Officer at Idera Pharmaceuticals, Inc. and Resilience Government Services, Inc. He was also the Chief Medical Officer at Aceragen, Inc. from 2021 to 2023.
Dr. Kraus received his undergraduate degree from Washington University School of Medicine.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 07-03-2024 | 262 500 ( 0.29% ) | 1 M $ | 30-04-2024 | |
ACERAGEN, INC.
-.--% | 17-01-2023 | 0 ( -.--% ) | - $ | 31-07-2023 |
Actieve functies van Carl Kraus
| Bedrijven | Functie | Begin |
|---|---|---|
| AQUESTIVE THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 26-06-2023 |
i3 Research, Inc.
 i3 Research, Inc. Miscellaneous Commercial ServicesCommercial Services i3 Research, Inc. undertakes medical research services. The company focuses on central nervous system, oncology, respiratory and infectious diseases, endocrinology and metabolic diseases, and cardiology. It offers clinical research solutions, including project management, investigator recruitment, patient recruitment, and regulatory services. The company is located in Basking Ridge, NJ. | Hoofd Techniek/Wetenschap/O&O | - |
Eerdere bekende functies van Carl Kraus
| Bedrijven | Functie | Einde |
|---|---|---|
| ACERAGEN, INC. | Hoofd Techniek/Wetenschap/O&O | 30-04-2023 |
Arrevus, Inc.
 Arrevus, Inc. BiotechnologyHealth Technology Arrevus, Inc. develops designer proline-rich antimicrobial peptide chaperone-protein inhibitors to treat diseases for which antibiotic resistance has clinical implications. The company was founded by Carl N. Kraus in 2015 and is headquartered in Raleigh, NC. | Algemeen Directeur | 31-10-2021 |
Idera Pharmaceuticals, Inc.
 Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. | Hoofd Techniek/Wetenschap/O&O | - |
Resilience Government Services, Inc.
 Resilience Government Services, Inc. Pharmaceuticals: MajorHealth Technology Resilience Government Services, Inc. engages in the development of biopharmaceutical products and medical devices. It also offers preclinical and clinical development, formulation optimization, and cGMP manufacturing. The company was founded by James D. Talton in 1999 and is headquartered in Alachua FL. | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Carl Kraus
| Washington University School of Medicine | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| AQUESTIVE THERAPEUTICS, INC. | Health Technology |
| ACERAGEN, INC. | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
Idera Pharmaceuticals, Inc.
Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. | Health Technology |
i3 Research, Inc.
i3 Research, Inc. Miscellaneous Commercial ServicesCommercial Services i3 Research, Inc. undertakes medical research services. The company focuses on central nervous system, oncology, respiratory and infectious diseases, endocrinology and metabolic diseases, and cardiology. It offers clinical research solutions, including project management, investigator recruitment, patient recruitment, and regulatory services. The company is located in Basking Ridge, NJ. | Commercial Services |
Resilience Government Services, Inc.
Resilience Government Services, Inc. Pharmaceuticals: MajorHealth Technology Resilience Government Services, Inc. engages in the development of biopharmaceutical products and medical devices. It also offers preclinical and clinical development, formulation optimization, and cGMP manufacturing. The company was founded by James D. Talton in 1999 and is headquartered in Alachua FL. | Health Technology |
Arrevus, Inc.
Arrevus, Inc. BiotechnologyHealth Technology Arrevus, Inc. develops designer proline-rich antimicrobial peptide chaperone-protein inhibitors to treat diseases for which antibiotic resistance has clinical implications. The company was founded by Carl N. Kraus in 2015 and is headquartered in Raleigh, NC. | Health Technology |
